SLXN CIK: 2022416

Silexion Therapeutics Corp

  • Israel
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−3.86
FY23:
−4.68
FY24:
−12.6
FY25:
−11.6
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
−11.8
(positive)
Change from FY22 to FY25
millions USD
FY22:
−3.46
FY23:
−5.08
FY24:
−16.5
FY25:
−11.9
(positive)
Change from FY23 to FY25
millions USD
FY22:
–
FY23:
−5.11
FY24:
−16.5
FY25:
−11.9

All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data